Diseases Causing Airway Obstruction in the Horse
Journal: Equine Respiratory Diseases
Summary
# Editorial Summary: Diseases Causing Airway Obstruction in the Horse Severe equine asthma (SEA) presents a naturally occurring inflammatory airway disease with pathological features—reversible bronchospasm, neutrophil infiltration, and Th2-mediated immune dysfunction—that closely mirror human asthma, positioning horses as a valuable translational model for testing novel therapeutics that preclinical rodent studies cannot adequately represent. Whilst conventional corticosteroid therapy reduces clinical signs and airway obstruction, it fails to arrest underlying pulmonary remodelling or prevent symptom persistence in many patients, both equine and human. Cell-based therapies using mesenchymal stromal cells (MSCs) and their derivatives—including conditioned medium and extracellular vesicles—offer a mechanistically distinct approach by potentially regenerating damaged lung tissue and modulating allergic responsiveness rather than simply suppressing inflammation. The structural similarity between equine and human airway pathology, particularly regarding tissue remodelling processes, makes the horse a uniquely practical intermediate model for evaluating whether MSC-derived therapies can reverse chronic lung changes before advancing to human trials. For equine practitioners managing chronic respiratory cases, this framework suggests that emerging cell therapies may eventually complement or supersede current corticosteroid-dependent protocols by addressing tissue repair alongside inflammatory control.
Read the full abstract on PubMed
Practical Takeaways
- •Current corticosteroid treatments for equine asthma manage symptoms but don't reverse lung damage—consider emerging cell-based therapies as potential adjunctive approaches
- •Understanding that equine asthma mirrors human disease pathology suggests evidence from equine studies may inform better therapeutic strategies for your affected horses
- •Cell therapy approaches targeting tissue regeneration rather than just inflammation suppression represent a promising future direction for managing chronic respiratory disease
Key Findings
- •Horses naturally develop asthma with striking parallels to human disease, including reversible bronchospasms and Th2-mediated neutrophil accumulation in lungs
- •Pulmonary remodelling in equine asthma closely resembles human asthma pathology, making horses a unique model for tissue repair investigation
- •Conventional corticosteroid therapy reduces airway obstruction but fails to reverse underlying lung pathology in both human and equine asthma
- •Mesenchymal stromal cell (MSC) therapy and derivatives may offer tissue regeneration and allergen tolerance advantages over conventional inflammatory modulation alone